All In Biotech

Drug Trial Radar · NCT03525574

A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

Last checked: Nov 19, 2026Latest source record: Sep 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

507

Actual

Start

Oct 9, 2018

Primary completion

Jan 9, 2023

Study completion Jan 9, 2023

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
May 15, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study evaluates the long-term safety and tolerability of VX-445 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are homozygous or heterozygous for the F508del mutation

Conditions

  • Cystic Fibrosis

Interventions

  • ELX/TEZ/IVADrug

    Fixed-dose combination (FDC) tablet for oral administration.

  • IVADrug

    Tablet for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Period: Safety and Tolerability as Assessed by Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From Day 1 up to Week 196

Locations

110 sites in 13 countries. Site status is shown where the registry gives one.

  • Banner University of Arizona Medical Center

    Tucson, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Miller Children's Hospital / Long Beach Memorial

    Long Beach, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Valley Children's Hospital

    Madera, California

  • Kaiser Permanente

    Oakland, California

  • University of California Davis Medical Center

    Sacramento, California

  • UCSF Gateway Medical Center

    San Francisco, California

  • National Jewish Health

    Denver, Colorado

  • University of Florida, Shands Hospital

    Gainesville, Florida

  • Joe DiMaggio Cystic Fibrosis & Pulmonary Center

    Hollywood, Florida

  • Nemours Children's Specialty Care

    Jacksonville, Florida

  • Central Florida Pulmonary Group, PA

    Orlando, Florida

  • Nemours Children's Hospital

    Orlando, Florida

  • Tampa General Hospital Cardiac and Lung Transplant Clinic

    Tampa, Florida

  • Children's Specialty Services at North Druid Hills

    Atlanta, Georgia

  • Augusta University

    Augusta, Georgia

  • Ann & Robert Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Cystic Fibrosis Center, Children's Hospital of Illinois at OSF Saint Francis Medical Center

    Peoria, Illinois

  • The University of Kansas Medical Center

    Kansas City, Kansas

  • Tulane Medical Center

    New Orleans, Louisiana

  • Maine Medical Partners

    Portland, Maine

  • Massachusetts General Hospital Cystic Fibrosis Center Clinical Research Center

    Boston, Massachusetts

  • Harper University Hospital

    Detroit, Michigan

  • Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota

    Minneapolis, Minnesota

  • Billings Clinic Hospital

    Billings, Montana

  • Nebraska Medical Center

    Omaha, Nebraska

  • Morristown Medical Center

    Morristown, New Jersey

  • UNM Clinical and Translational Science Center

    Albuquerque, New Mexico

  • The Cystic Fibrosis Center, Mount Sinai Beth Israel

    New York, New York

  • New York Medical College

    Valhalla, New York

  • UNC Marsico Clinical Research Center

    Chapel Hill, North Carolina

  • Akron Children's Hospital

    Akron, Ohio

  • UC Health Holmes

    Cincinnati, Ohio

  • Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Dayton Children's Hospital

    Dayton, Ohio

  • ProMedica Toledo Hospital/Toledo Children's Hospital/Pediatric Pulmonary & Cystic Fibrosis Center

    Toledo, Ohio

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

Showing 40 of 110 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.